SLIDESHOW

The M&A Scene: CEO Leadership
Dealmakers gathered at the Harvard Club in New York on May 7 as part of ACG NY's CEO Leadership event. Peter Gonye, a co-leader within Spencer Stuart's private equity practice in North America was the keynote speaker. Panelists included M. Tatum Pursell, senior adviser, Unlimited Horizons; Tony Ecock, general partner, Welsh Carson Anderson & Stowe; Jim Follett, former CEO of Authentic Response Inc.; Doron Grosman, operating partner, Court Square Capital; and Joelle Marquis, partner, Arsenal Capital.

Watercooler

3Qs With... Chris Randall, executive vice president, NBH Capital Finance
NBH Capital Finance will focus on the lower middle market

Dealmakers

Time Inc. -Meredith Pairing Would Have Been Too Complicated, Says Jeff Bewkes in Keynote
The Time Warner chairman hints there may be a future deal for the spun-off magazine business, maybe even with Meredith

Columns

The Buyside:
Trench Dealfare

Strategic players in the aerospace and defense sector look to offset losses by remaining on the hunt for targets

Today’s Transactions:
Merit Medical the Latest to Buy a Catheter Company

Following Boston Scientific’s lead, Merit Medical buys Thomas Medical from GE Healthcare

Merit Medical Systems Inc. (Nasdaq: MMSI) will acquire Thomas Medical Products Inc. from GE Healthcare for $167 million.

Thomas Medical, headquartered in Malvern, Pa., makes catheter-based vascular devices. South Jordan, Utah-based Merit makes and markets disposable supplies used in cardiology, radiology and endoscopy.

Merit will complete the deal through an expansion of its credit facility from Wells Fargo Bank to $275 million.

Piper Jaffray & Co. served as Merit’s financial adviser and offered a fairness opinion to Merit’s board of directors, Raymond James Financial Inc. also provided an opinion to the board, and Parr Brown Gee & Loveless served as the company’s legal adviser. Moelis & Co. LLC served as GE’s financial adviser, while Paul Hastings LLP served as legal counsel.

The deal was announced on the heals of two other acquisitions that centered on catheter technology. Boston Scientific Corp. (NYSE: BSX), a Natick, Mass.-based medical device manufacturer, paid $125 million for Vessix Vascular Inc. about one month after it spent $265 million for Rhythmia Medical Inc.

 

For more information on related topics, visit the following: